Lemonade Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.9% | +0.8% | +4.1% | +6.4% | +1.4% | +0.4% | +4.2% | -0.8% | +0.4% | +1.7% | +2.8% | |
| – | +53.6% | -6.5% | +7.7% | +61.4% | +31.9% | -19.8% | +5.0% | -8.2% | +35.3% | -29.0% | -33.5% | |
| – | +14.2% | +5.4% | +23.1% | -3.9% | +14.0% | -17.8% | +22.1% | -8.4% | +11.3% | -2.8% | -1.8% | |
| – | +68.0% | -1.8% | +0.4% | -36.7% | +72.7% | -36.7% | +4.8% | -12.5% | +88.8% | -47.8% | -3.1% | |
| – | +4.1% | +6.3% | +13.6% | +5.4% | -1.7% | +4.4% | +4.9% | +7.3% | +0.9% | +4.7% | -17.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -9.1% | -10.5% | -11.2% | +52.2% | -6.9% | -12.4% | -5.3% | +0.9% | -6.5% | +10.4% | -63.7% | |
| – | +0.4% | +4.9% | +11.2% | +14.0% | +2.1% | +4.4% | +7.4% | -0.3% | -0.7% | +3.4% | +5.0% | |
| – | +415.9% | -12.9% | +7.0% | +508.3% | +0.6% | +3.4% | +6.4% | -1.0% | -3.3% | +2.4% | +3.8% | |
| – | +224.7% | +13.2% | +55.1% | +53.5% | +37.1% | +10.3% | – | – | +18.9% | +8.7% | +14.9% | |
| – | -36.9% | +10.6% | +26.8% | +24.3% | -27.5% | +0.3% | +10.9% | -22.0% | -0.4% | +17.5% | -12.0% | |
| – | +93.5% | +89.9% | +55.1% | +53.5% | +23.7% | +22.2% | +21.2% | +12.6% | +13.7% | +13.6% | +14.9% | |
| – | -2.5% | -4.6% | -6.1% | -6.6% | +0.1% | -8.1% | -3.4% | -2.1% | +3.4% | -2.9% | -3.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +0.4% | +0.6% | +0.6% | -0.2% | +2.7% | +0.7% | +1.0% | -3.2% | +6.3% | +0.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.